186 research outputs found
Methodische Bewertung von Originalartikeln zu Radiomics und Machine Learning für Outcome-Vorhersagen basierend auf der Positronen-Emissions-Tomografie (PET)
AIM
Despite a vast number of articles on radiomics and machine learning in positron emission tomography (PET) imaging, clinical applicability remains limited, partly owing to poor methodological quality. We therefore systematically investigated the methodology described in publications on radiomics and machine learning for PET-based outcome prediction.
METHODS
A systematic search for original articles was run on PubMed. All articles were rated according to 17 criteria proposed by the authors. Criteria with >2 rating categories were binarized into "adequate" or "inadequate". The association between the number of "adequate" criteria per article and the date of publication was examined.
RESULTS
One hundred articles were identified (published between 07/2017 and 09/2023). The median proportion of articles per criterion that were rated "adequate" was 65% (range: 23-98%). Nineteen articles (19%) mentioned neither a test cohort nor cross-validation to separate training from testing. The median number of criteria with an "adequate" rating per article was 12.5 out of 17 (range, 4-17), and this did not increase with later dates of publication (Spearman's rho, 0.094; p = 0.35). In 22 articles (22%), less than half of the items were rated "adequate". Only 8% of articles published the source code, and 10% made the dataset openly available.
CONCLUSION
Among the articles investigated, methodological weaknesses have been identified, and the degree of compliance with recommendations on methodological quality and reporting shows potential for improvement. Better adherence to established guidelines could increase the clinical significance of radiomics and machine learning for PET-based outcome prediction and finally lead to the widespread use in routine clinical practice
Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
Facilitating accurate diagnosis and ensuring appropriate treatment of dementia subtypes, including Alzheimer's disease (AD), Parkinson's disease dementia (PDD), and Lewy body dementia (DLB), is clinically important. However, the differences in glucose metabolic distribution among these three dementia subtypes are minor, which can result in difficulties in diagnosis by visual assessment or traditional quantification methods. Here, we explored this issue using novel approaches, including brain network and abnormal hemispheric asymmetry analyses. We generated 18F-labeled fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) images from patients with AD, PDD, and DLB, and healthy control (HC) subjects (n = 22, 18, 22, and 22, respectively) from Huashan hospital, Shanghai, China. Brain network properties were measured and between-group differences evaluated using graph theory. We also calculated and explored asymmetry indices for the cerebral hemispheres in the four groups, to explore whether differences between the two hemispheres were characteristic of each group. Our study revealed significant differences in the network properties of the HC and AD groups (small-world coefficient, 1.36 vs. 1.28; clustering coefficient, 1.48 vs. 1.59; characteristic path length, 1.57 vs. 1.64). In addition, differing hub regions were identified in the different dementias. We also identified rightward asymmetry in the hemispheric brain networks of patients with AD and DLB, and leftward asymmetry in the hemispheric brain networks of patients with PDD, which were attributable to aberrant topological properties in the corresponding hemispheres
Phantom study for 90Y post-treatment dosimetry with a long axial field-of-view PET/CT
Purpose: The physical properties of yttrium-90 (90Y) allow for imaging with
positron emission tomography/computed tomography (PET/CT). The increased
sensitivity of long axial field-of-view (LAFOV) PET/CT scanners possibly allows
to overcome the small branching ratio for positron production from 90Y decays
and to improve for the post-treatment dosimetry of 90Y of selective internal
radiation therapy.
Methods: For the challenging case of an image quality body phantom, we
compare a full Monte Carlo (MC) dose calculation with the results from the two
commercial software packages Simplicit90Y and Hermes. The voxel dosimetry
module of Hermes relies on the 90Y images taken with a LAFOV PET/CT, while the
MC and Simplicit90Y dose calculations are image independent.
Results: The resulting doses from the MC calculation and Simplicit90Y agree
well within the error margins. The image-based dose calculation with Hermes,
however, consistently underestimates the dose. This is due to the mismatch of
the activity distribution in the PET images and the size of the volume of
interest. Furthermore, there are likely limitations of Hermes' dose calculation
algorithm for 90Y. We found that only for the smallest phantom sphere there is
a statistically significant dependence of the Hermes dose on the image
reconstruction parameters and scan time.
Conclusion: Our study shows that Simplicit90Y's local deposition model can
provide a reliable dose estimate. On the other hand, the image based dose
calculation requires further benchmarks and verification in order to take full
advantage of LAFOV PET/CT systems
Recommended from our members
Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients.
Recently introduced long-axial field-of-view (LAFOV) PET/CT systems represent one of the most significant advancements in nuclear medicine since the advent of multi-modality PET/CT imaging. The higher sensitivity exhibited by such systems allow for reductions in applied activity and short duration scans. However, we consider this to be just one small part of the story: Instead, the ability to image the body in its entirety in a single FOV affords insights which standard FOV systems cannot provide. For example, we now have the ability to capture a wider dynamic range of a tracer by imaging it over multiple half-lives without detrimental image noise, to leverage lower radiopharmaceutical doses by using dual-tracer techniques and with improved quantification. The potential for quantitative dynamic whole-body imaging using abbreviated protocols potentially makes these techniques viable for routine clinical use, transforming PET-reporting from a subjective analysis of semi-quantitative maps of radiopharmaceutical uptake at a single time-point to an accurate and quantitative, non-invasive tool to determine human function and physiology and to explore organ interactions and to perform whole-body systems analysis. This article will share the insights obtained from 2 years' of clinical operation of the first Biograph Vision Quadra (Siemens Healthineers) LAFOV system. It will also survey the current state-of-the-art in PET technology. Several technologies are poised to furnish systems with even greater sensitivity and resolution than current systems, potentially with orders of magnitude higher sensitivity. Current barriers which remain to be surmounted, such as data pipelines, patient throughput and the hindrances to implementing kinetic analysis for routine patient care will also be discussed
- …